Neuphoria Therapeutics Inc. (NEUP)
NASDAQ: NEUP · Real-Time Price · USD
4.425
+0.025 (0.57%)
Mar 20, 2026, 2:48 PM EDT - Market open
Neuphoria Therapeutics Market Cap
Neuphoria Therapeutics has a market cap or net worth of $23.85 million as of March 20, 2026. Its market cap has increased by 175.95% in one year.
Market Cap
23.85M
Enterprise Value
1.58M
1-Year Change
175.95%
Ranking
Category
Stock Price
$4.43
Market Cap Chart
Since December 24, 2024, Neuphoria Therapeutics's market cap has increased from $10.79M to $23.85M, an increase of 121.11%. That is a compound annual growth rate of 90.60%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 18, 2026 | 24.64M | 18.08% |
| Dec 31, 2025 | 20.86M | 273.80% |
| Dec 31, 2024 | 5.58M | -48.27% |
| Dec 24, 2024 | 10.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Boundless Bio | 25.77M |
| Enlivex | 25.77M |
| Barinthus Biotherapeutics | 25.73M |
| Vistagen Therapeutics | 25.45M |
| IGC Pharma | 25.26M |
| Lantern Pharma | 24.16M |
| Senti Biosciences | 23.68M |
| Passage Bio | 23.67M |